RhTFAM treatment stimulates mitochondrial oxidative metabolism and improves memory in aged mice

Aging

Volumn 4, Issue 9, 2012, Pages 620-635

  Thomas, Ravindar R ^a   Kha, Shaharyar M ^b   Smigrodzki, Rafal M ^b   Onyango, Isaac G ^b   Dennis, Jameel ^b   Khan, Omer M ^b   Portell, Francisco R ^b   Bennett, James P ^a,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Gencia Corporation   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Mitobiogenesis; Mitochondrial DNA; Recombinant human TFAM

Indexed keywords

EID: 84872577068     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100488     Document Type: Article

References (54)

1. Harman D. Aging: a theory based on free radical and radiation chemistry. Journal of gerontology. 1956; 11:298-300.
2. Harman D. The free radical theory of aging. Antioxidants & redox signaling. 2003; 5:557-561.
3. Lapointe J and Hekimi S. When a theory of aging ages badly. Cellular and molecular life sciences CMLS. 2010; 67:1-8.
4. Gruber J, Schaffer S and Halliwell B. The mitochondrial free radical theory of ageing-where do we stand? Frontiers in bioscience a journal and virtual library. 2008; 13:6554-6579.
5. Jang YC, Perez VI, Song W, Lustgarten MS, Salmon AB, Mele J, Qi W, Liu Y, Liang H, Chaudhuri A, Ikeno Y, Epstein CJ, Van Remmen H, et al. Overexpression of Mn superoxide dismutase does not increase life span in mice. The journals of gerontology Series A, Biological sciences and medical sciences. 2009; 64:1114-1125.
6. Jang YC and Remmen VH. The mitochondrial theory of aging: insight from transgenic and knockout mouse models. Experimental gerontology. 2009; 44:256-260.
7. Hur JH, Cho J and Walker DW. Aging: Dial M for Mitochondria. Aging. 2010; 2:69-73.
8. Vina J, Gomez-Cabrera MC, Borras C, Froio T, Sanchis-Gomar F, Martinez-Bello VE and Pallardo FV. Mitochondrial biogenesis in exercise and in ageing. Advanced drug delivery reviews. 2009; 61:1369-1374.
9. Johnston AP, De Lisio M and Parise G. Resistance training, sarcopenia, and the mitochondrial theory of aging. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme. 2008; 33:191-199.
10. Gems D and Doonan R. Antioxidant defense and aging in C. elegans: is the oxidative damage theory of aging wrong? Cell Cycle. 2009; 8:1681-1687.
11. Hwang AB and Lee SJ. Regulation of life span by mitochondrial respiration: the HIF-1 and ROS connection. Aging. 2011; 3:304-310.
12. Gems D and Guardia YD. Alternative Perspectives on Aging in Caenorhabditis elegans: Reactive Oxygen Species or Hyperfunction? Antioxidants & redox signaling. 2012.
13. Blagosklonny MV. Aging: ROS or TOR. Cell Cycle. 2008; 7:3344-3354.
14. Pani G. P66SHC and ageing: ROS and TOR? Aging. 2010; 2:514-518.
15. Anisimov VN, Egorov MV, Krasilshchikova MS, Lyamzaev KG, Manskikh VN, Moshkin MP, Novikov EA, Popovich IG, Rogovin KA, Shabalina IG, Shekarova ON, Skulachev MV, Titova TV, et al. Effects of the mitochondria-targeted antioxidant SkQ1 on lifespan of rodents. Aging. 2011; 31110-1119.
16. Skulachev VP. SkQ1 treatment and food restriction-two ways to retard an aging program of organisms. Aging. 2011; 3:1045-1050.
17. Choksi KB, Nuss JE, DeFord JH and Papaconstantinou J. Mitochondrial electron transport chain functions in long-lived. Aging. 2011; 3:754-767.
18. Ago T, Matsushima S, Kuroda J, Zablocki D, Kitazono T and Sadoshima J. The NADPH oxidase Nox4 and aging in the heart. Aging. 2010; 2:1012-1016.
19. Kuroda J, Ago T, Matsushima S, Zhai P, Schneider MD and Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proceedings of the National Academy of Sciences of the United States of America. 2010; 107:15565-15570.
20. Schulz TJ, Westermann D, Isken F, Voigt A, Laube B, Thierbach R, Kuhlow D, Zarse K, Schomburg L, Pfeiffer AF, Tschope C and Ristow M. Activation of mitochondrial energy metabolism protects against cardiac failure. Aging. 2010; 2:843-853.
21. Iyer S, Thomas RR, Portell FR, Dunham LD, Quigley CK and Bennett JP, Jr. Recombinant mitochondrial transcription factor A with N-terminal mitochondrial transduction domain increases respiration and mitochondrial gene expression. Mitochondrion. 2009; 9:196-203.
22. Iyer S, Xiao E, Alsayegh K, Eroshenko N, Riggs MJ, Bennett JP, Jr. and Rao RR. Mitochondrial gene replacement in human pluripotent stem cell-derived neural progenitors. Gene therapy. 2011.
23. Keeney PM, Quigley CK, Dunham LD, Papageorge CM, Iyer S, Thomas RR, Schwarz KM, Trimmer PA, Khan SM, Portell FR, Bergquist KE and Bennett JP, Jr. Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model. Human gene therapy. 2009; 20:897-907.
24. Thomas RR, Khan SM, Portell FR, Smigrodzki RM and Bennett JP, Jr. Recombinant human mitochondrial transcription factor A stimulates mitochondrial biogenesis and ATP synthesis, improves motor function after MPTP, reduces oxidative stress and increases survival after endotoxin. Mitochondrion. 2011; 11:108-118.
25. Iyer S, Bergquist K, Young K, Gnaiger E, Rao RR and Bennett JP, Jr. Mitochondrial Gene Therapy Improves Respiration, Biogenesis, and Transcription in G11778A Leber's Hereditary Optic Neuropathy and T8993G Leigh's Syndrome Cells. Human gene therapy. 2012.
26. Scarpulla RC. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta. 2011; 1813:1269-1278.
27. Horio Y, Hayashi T, Kuno A and Kunimoto R. Cellular and molecular effects of sirtuins in health and disease. Clin Sci (Lond). 2011; 121:191-203.
28. Lombard DB, Tishkoff DX and Bao J. Mitochondrial sirtuins in the regulation of mitochondrial activity and metabolic adaptation. Handbook of experimental pharmacology. 2011; 206:163-188.
29. Verdin E, Hirschey MD, Finley LW and Haigis MC. Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends in biochemical sciences. 2010; 35:669-675.
30. Pruunsild P, Sepp M, Orav E, Koppel I and Timmusk T. Identification of cis-elements and transcription factors regulating neuronal activity-dependent transcription of human BDNF gene. The Journal of neuroscience the official journal of the Society for Neuroscience. 2011; 31:3295-3308.
31. Robinet C and Pellerin L. Brain-derived neurotrophic factor enhances the hippocampal expression of key postsynaptic proteins in vivo including the monocarboxylate transporter MCT2. Neuroscience. 2011; 192:155-163.
32. Vaynman S, Ying Z and Gomez-Pinilla F. Interplay between brain-derived neurotrophic factor and signal transduction modulators in the regulation of the effects of exercise on synaptic-plasticity. Neuroscience. 2003; 122:647-657.
33. Vaynman S, Ying Z and Gomez-Pinilla F. Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. The European journal of neuroscience. 2004; 20:2580-2590.
34. Vaynman S, Ying Z and Gomez-Pinilla F. Exercise induces BDNF and synapsin I to specific hippocampal subfields. Journal of neuroscience research. 2004; 76:356-362.
35. Hartmann N, Reichwald K, Wittig I, Drose S, Schmeisser S, Luck C, Hahn C, Graf M, Gausmann U, Terzibasi E, Cellerino A, Ristow M, Brandt U, et al. Mitochondrial DNA copy number and function decrease with age in the short-lived fish Nothobranchius furzeri. Aging cell. 2011; 10:824-831.
36. Navarro A, Lopez-Cepero JM, Bandez MJ, Sanchez-Pino MJ, Gomez C, Cadenas E and Boveris A. Hippocampal mitochondrial dysfunction in rat aging. Am J Physiol Regul Integr Comp Physiol. 2008; 294:R501-509.
37. Yokoyama H, Uchida H, Kuroiwa H, Kasahara J and Araki T. Role of glial cells in neurotoxin-induced animal models of Parkinson's disease. Neurol Sci. 32:1-7.
38. Bauereis B, Haskins WE, Lebaron RG and Renthal R. Proteomic insights into the protective mechanisms of an in vitro oxidative stress model of early stage Parkinson's disease. Neurosci Lett. 488:11-16.
39. Imam SZ, Zhou Q, Yamamoto A, Valente AJ, Ali SF, Bains M, Roberts JL, Kahle PJ, Clark RA and Li S. Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's disease. J Neurosci. 31:157-163.
40. Aridon P, Geraci F, Turturici G, D'Amelio M, Savettieri G and Sconzo G. Protective Role of Heat Shock Proteins in Parkinson's Disease. Neurodegener Dis.
41. Bian Z, Li LM, Tang R, Hou DX, Chen X, Zhang CY and Zen K. Identification of mouse liver mitochondria-associated miRNAs and their potential biological functions. Cell research. 2010; 20:1076-1078.
42. Davidsen PK, Gallagher IJ, Hartman JW, Tarnopolsky MA, Dela F, Helge JW, Timmons JA and Phillips SM. High responders to resistance exercise training demonstrate differential regulation of skeletal muscle microRNA expression. J Appl Physiol. 2011; 110:309-317.
43. Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O, Troconso JC, Dawson VL and Dawson TM. PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease. Cell. 2011; 144:689-702.
44. Kang D, Kim SH and Hamasaki N. Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions. Mitochondrion. 2007; 7:39-44.
45. De Araujo DP, Lobato Rde F, Cavalcanti JR, Sampaio LR, Araujo PV, Silva MC, Neves KR, Fonteles MM, Sousa FC and Vasconcelos SM. The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review. Int J Neurosci. 121:51-57.
46. Kim SC, Sprung R, Chen Y, Xu Y, Ball H, Pei J, Cheng T, Kho Y, Xiao H, Xiao L, Grishin NV, White M, Yang XJ, et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Molecular cell. 2006; 23:607-618.
47. Hirayama M, Nakamura T, Watanabe H, Uchida K, Hama T, Hara T, Niimi Y, Ito M, Ohno K and Sobue G. Urinary 8- hydroxydeoxyguanosine correlate with hallucinations rather than motor symptoms in Parkinson's disease. Parkinsonism Relat Disord. 17:46-49.
48. Kong X, Wang R, Xue Y, Liu X, Zhang H, Chen Y, Fang F and Chang Y. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PloS one. 2010; 5:e11707.
49. Hayashi Y, Yoshida M, Yamato M, Ide T, Wu Z, Ochi-Shindou M, Kanki T, Kang D, Sunagawa K, Tsutsui H and Nakanishi H. Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor a in mice. J Neurosci. 2008; 28:8624-8634.
50. Rogers DC and Hagan JJ. 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology. 2001; 158:114-119.
51. Hernandez CM, Gearhart DA, Parikh V, Hohnadel EJ, Davis LW, Middlemore ML, Warsi SP, Waller JL and Terry AV, Jr. Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats. J Pharmacol Exp Ther. 2006; 316:679-694.
52. Shuman T, Wood SC and Anagnostaras SG. Modafinil and memory: effects of modafinil on Morris water maze learning and Pavlovian fear conditioning. Behavioral neuroscience. 2009; 123:257-266.
53. Hansalik M, Skalicky M and Viidik A. Impairment of water maze behaviour with ageing is counteracted by maze learning earlier in life but not by physical exercise, food restriction or housing conditions. Experimental gerontology. 2006; 41:169-174.
54. Caviness JN, Lue L, Adler CH and Walker DG. Parkinson's disease dementia and potential therapeutic strategies. CNS Neurosci Ther. 17:32-44.